ELIZABETH DOTY: Open Payments
NPI 1558853515 · WETHERSFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,911 in 84 payments from 17 companies in 2025. Trend: 2023 $1,207 · 2024 $1,324 · 2025 $1,911
Food & beverage: $1,811Education: $100
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $308 |
| Regeneron Healthcare Solutions, Inc. | 10 | $302 |
| Novartis Pharmaceuticals Corporation | 12 | $188 |
| Optinose US, Inc. | 11 | $151 |
| AstraZeneca Pharmaceuticals LP | 7 | $149 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $116 |
| CSL Behring | 4 | $113 |
| GlaxoSmithKline, LLC. | 5 | $111 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Genentech USA, Inc. | 4 | $91 |
Products named: DUPIXENT, Xhance, NUCALA, Xolair, AIRSUPRA, Hizentra, TEZSPIRE, CUVITRU.
Industry payments across CT — which companies pay providers there.
